These biotech stocks are generating big returns for investors that make them worth watching.
What I saw this weekend could be a “HUGE” opportunity for you to make some serious money in 2018.
Warren Buffett recently boosted his stake in Monsanto, and Bill Ackman took a new position in Nike. Here's what we can glean from their decisions.
One of the most interesting IPOs of 2017 is joining my portfolio this month. It should join yours, too.
It all comes down to speed, access, and ambition.
If you're not looking at this space for more gains, history suggests you're going to miss out.
Rite Aid, Glu Mobile, and Groupon could claw their way out of their low single-digit prices this year.
There’s still time to put your money where your mouth is and capture some big profits from this explosive opportunity!
Twitter's soaring stock price is putting pressure on the social network to sustain its return to growth.
If you’re going after new stocks, you need to know how to trade the IPO sweet spot.